Peter Hodson Response Biomedical RBM-T BUY Aug 28, 2006

Does medical testing which is a big, big market. Have all the approvals they need and just need to sell a few more testers. Likes the long-term potential, so picks away at it. Good management team.

Peter Hodson

Owned

Unlock Rating

$0.500

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WAIT

Has some potential.

WEAK BUY

Tecnhnology soundds attractive, but work has to be done yet.

BUY

Led by one of the most reputable and solid management teams in healthcare. In food agnostics right now and has the right partners. Diversified with 2 products, a hospital cardiac diagnostic tool.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Peter Hodson Response Biomedical RBM-T BUY Aug 28, 2006

You might be interested:

Response Biomedical(RBM-T)

Response Biomedical(RBM-T)

Response Biomedical(RBM-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights